Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19

Related articles

1. Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial

   This article has 28 authors:

   1. Carolyn T. Bramante
   2. Thomas G. Stewart
   3. David R. Boulware
   4. Matthew W. McCarthy
   5. Yue Gao
   6. Russell L. Rothman
   7. Ahmad Mourad
   8. Florence Thicklin
   9. Jonathan B. Cohen
   10. Idania T. Garcia del Sol
   11. Nirav S. Shah
   12. Manisha Mehta
   13. Orlando Quintero Cardona
   14. Jake Scott
   15. Adit A. Ginde
   16. Mario Castro
   17. Dushyantha Jayaweera
   18. Mark Sulkowski
   19. Nina Gentile
   20. Kathleen McTigue
   21. G. Michael Felker
   22. Sean Collins
   23. Sarah E. Dunsmore
   24. Stacey J. Adam
   25. Christopher J. Lindsell
   26. Adrian F. Hernandez
   27. Susanna Naggie
   28. the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators

2. Immunobridging Analysis of Pemivibart for the Treatment of COVID-19 – A Therapeutic Gap for the Immune Compromised Remains

   This article has 5 authors:

   1. Anna Holmes
   2. Kristin Narayan
   3. Ilker Yalcin
   4. Leijun Hu
   5. Mark A. Wingertzahn

3. Comparison of IMC-2 alone and IMC-2 and Paxlovid® shows substantial short and long-term efficacy in reducing symptoms of Long COVID with combination therapy: a case series

   This article has 2 authors:

   1. David Putrino
   2. William Pridgen